Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


1.		A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 and under				NICHD				PPRU 10762 NCT00491946

Last Modified: 10/15/2008 First Published: 7/1/2001


2.		Phase III Randomized Study of Standard Induction Chemotherapy Comprising Vincristine, Dactinomycin, Ifosfamide, and Etoposide Followed By Consolidation Chemotherapy Comprising Vincristine, Dactinomycin, and Ifosfamide Versus High-Dose Busulfan and Melphalan Followed By Autologous Peripheral Blood Stem Cell Support With or Without Radiotherapy and/or Surgery in Patients With Tumor of the Ewing's Family

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 50				NCI, Other				EURO-EWING-INTERGROUP-EE99 EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, NCT00020566, AEWS0331

Last Modified: 1/23/2007 First Published: 10/1/2002


3.		Phase III Partially Randomized Study of Neoadjuvant Chemotherapy Followed By Surgery and Adjuvant Chemotherapy in Children With Wilms' Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and under				Other				SIOP-WT-2001 SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138

Last Modified: 10/15/2008 First Published: 12/23/2003


4.		Phase III Study of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 50				NCI				COG-ARST0331 NCT00075582, ARST0331

Last Modified: 9/29/2008 First Published: 7/7/2006


5.		Phase III Study of Adjuvant Vincristine and Dactinomycin With or Without Doxorubicin Hydrochloride and Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 30 at diagnosis				NCI				COG-AREN0532 AREN0532, NCT00352534

Last Modified: 10/15/2008 First Published: 7/14/2006


6.		Phase III Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy in Patients With Newly Diagnosed, Intermediate-Risk Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 50				NCI				COG-ARST0531 NCT00354835, ARST0531

Last Modified: 5/30/2008 First Published: 9/15/2006


7.		Phase III Study of Combination Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed Stage III or IV Favorable Histology Wilms' Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 30				NCI				COG-AREN0533 AREN0533, NCT00379340

Last Modified: 11/30/2006 First Published: 9/15/2006


8.		Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 21				Other				CCLG-EPSSG-RMS-2005 EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457

Last Modified: 12/11/2006 First Published: 10/1/2001


9.		Phase II Study of Chemotherapy Followed By Surgical Resection and Adjuvant Radiotherapy With or Without Autologous Stem Cell Rescue in Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Under 18				Other				CCLG-UKWR EU-20127, NCT00025103

Last Modified: 10/30/2007 First Published: 10/21/2005


10.		Phase II Study of Intensive Chemotherapy Comprising Vincristine, Dactinomycin, and Cyclophosphamide Followed By Vincristine and Dactinomycin in Patients With Lower-Risk Embryonal Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Under 18				Other				JRSG-UHA-PED03-02 NCT00245089

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute